装有白胺的外体细胞增强了抗瘤治疗疗效,并降低了毒性
Sana Shaikh1, Muhammad Younis2, Shao Yingying1
1Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Biochemistry and Molecular Biology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
Life sciences
|July 27, 2023
概括
装有白色素 (BLM) 的瘤向外体提供了一种新的癌症治疗方法. 这种天然的输送系统增强了抗瘤活性,同时降低了毒性副作用,为更安全的化疗铺平了道路.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症治疗方法 癌症治疗方法
背景情况:
- 白素 (BLM) 是一种有效的化疗药物,但其使用受到肺纤维化症的限制.
- 针对瘤的BLM药物治疗对于提高疗效和降低毒性至关重要.
- 瘤衍生的外体细胞因其细胞向性质而显示出作为天然药物递送载体的潜力.
研究的目的:
- 开发一种使用色素 (Exo-BLM) 装载的外体的自然输送平台.
- 评估EXO-BLM的治疗疗效和瘤向能力.
- 评估EXO-BLM在癌症治疗中的安全性和有效性.
主要方法:
- 外体从癌细胞中分离出来,并充满了白血素.
- 使用传输电子显微镜,西部污点和纳米粒子跟踪分析对外体的表征.
- 进行了体外和体内研究,以评估EXO-BLM的抗癌作用.
主要成果:
- 埃克索-BLM显示出高向癌症的能力,并通过活性氧物种 (ROS) 诱导瘤细胞细胞毒性.
- 光成像证实了Exo-BLM在癌细胞中的积累.
- 外BLM治疗通过caspase途径诱导瘤细胞亡,并在体内增强抗瘤活性.
结论:
- 这项研究为向白色胺素 (BLM) 治疗提供了一个有希望的方法.
- 通过外体介导的BLM的输送为癌症治疗提供了一种潜在减少副作用的策略.
- 埃克索-BLM是一种可行的天然输送系统,可以提高化疗的有效性.
相关概念视频
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


